vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and VinFast Auto Ltd. (VFS). Click either name above to swap in a different company.
VinFast Auto Ltd. is the larger business by last-quarter revenue ($718.6M vs $622.0M, roughly 1.2× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs -2.8%, a 37.2% gap on every dollar of revenue.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
VinFast Auto Ltd. is a Vietnamese multinational automotive company founded by Vingroup, one of the largest private conglomerates in Vietnam that was founded by Phạm Nhật Vượng.
RPRX vs VFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $718.6M |
| Net Profit | $214.2M | $-20.0M |
| Gross Margin | — | — |
| Operating Margin | 62.4% | -96.1% |
| Net Margin | 34.4% | -2.8% |
| Revenue YoY | 4.8% | — |
| Net Profit YoY | 2.9% | — |
| EPS (diluted) | $0.49 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | — | ||
| Q3 25 | $609.3M | $718.6M | ||
| Q2 25 | $578.7M | $663.0M | ||
| Q1 25 | $568.2M | $656.5M | ||
| Q4 24 | $593.6M | — | ||
| Q3 24 | $564.7M | $511.6M | ||
| Q2 24 | $537.3M | — | ||
| Q1 24 | $568.0M | $302.6M |
| Q4 25 | $214.2M | — | ||
| Q3 25 | $288.2M | $-20.0M | ||
| Q2 25 | $30.2M | $-51.8M | ||
| Q1 25 | $238.3M | $-26.1M | ||
| Q4 24 | $208.2M | — | ||
| Q3 24 | $544.0M | $-10.4M | ||
| Q2 24 | $102.0M | — | ||
| Q1 24 | $4.8M | $-618.3M |
| Q4 25 | 62.4% | — | ||
| Q3 25 | 70.1% | -96.1% | ||
| Q2 25 | 36.3% | -79.0% | ||
| Q1 25 | 94.0% | -74.0% | ||
| Q4 24 | 60.9% | — | ||
| Q3 24 | — | -65.9% | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | -13.0% | -139.4% |
| Q4 25 | 34.4% | — | ||
| Q3 25 | 47.3% | -2.8% | ||
| Q2 25 | 5.2% | -7.8% | ||
| Q1 25 | 41.9% | -4.0% | ||
| Q4 24 | 35.1% | — | ||
| Q3 24 | 96.3% | -2.0% | ||
| Q2 24 | 19.0% | — | ||
| Q1 24 | 0.8% | -204.3% |
| Q4 25 | $0.49 | — | ||
| Q3 25 | $0.67 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $0.55 | — | ||
| Q4 24 | $0.46 | — | ||
| Q3 24 | $1.21 | — | ||
| Q2 24 | $0.23 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $8.8M |
| Total DebtLower is stronger | $9.0B | — |
| Stockholders' EquityBook value | $9.7B | — |
| Total Assets | $19.6B | $183.2M |
| Debt / EquityLower = less leverage | 0.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | — | ||
| Q3 25 | $938.9M | $8.8M | ||
| Q2 25 | $631.9M | $650.0M | ||
| Q1 25 | $1.1B | $2.4M | ||
| Q4 24 | $929.0M | — | ||
| Q3 24 | $950.1M | $1.9M | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $843.0M | $3.0M |
| Q4 25 | $9.0B | — | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.0B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | $7.6B | — | ||
| Q1 24 | $6.1B | — |
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | — | ||
| Q2 25 | $9.5B | $-7.2B | ||
| Q1 25 | $9.8B | — | ||
| Q4 24 | $10.3B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.8B | — | ||
| Q1 24 | $9.9B | — |
| Q4 25 | $19.6B | — | ||
| Q3 25 | $19.3B | $183.2M | ||
| Q2 25 | $18.3B | $7.2B | ||
| Q1 25 | $17.6B | $158.2M | ||
| Q4 24 | $18.2B | — | ||
| Q3 24 | $18.0B | $151.8M | ||
| Q2 24 | $17.7B | — | ||
| Q1 24 | $16.1B | $145.6M |
| Q4 25 | 0.92× | — | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | — | ||
| Q3 25 | $702.6M | — | ||
| Q2 25 | $364.0M | — | ||
| Q1 25 | $596.1M | — | ||
| Q4 24 | $742.5M | — | ||
| Q3 24 | $703.6M | — | ||
| Q2 24 | $658.2M | — | ||
| Q1 24 | $664.6M | — |
| Q4 25 | 3.86× | — | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 12.06× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 6.45× | — | ||
| Q1 24 | 139.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
VFS
| Sales of vehicles | $662.9M | 92% |
| Sales of spare parts and components | $41.3M | 6% |
| Revenue from leasing activities | $12.3M | 2% |
| Finance income | $2.4M | 0% |
| Rendering of services | $1.2M | 0% |
